UnitedHealth Group Incorporated (UNH) will probably climb 26.52 percent over the next 12 months, according to price target estimates compiled by finviz. Meanwhile, they have set a $335price as 12-month high target. This represents a whopping 36.81 percent increase from where shares are trading today. The 12-month median price target assigned by the analysts stands at $310, which represents a return potential of 26.6 percent when compared to the closing price of the stock of $244.87 on Thursday, January 10. The lowest price target for the stock is $218 — slightly more than -10.97 percent from UNH’s current share price.
The stock is currently hovering around the first support level of $242.47. Below this, the next support is placed in the zone of $240.08. Till the time, the UNH stock trades above this level, bulls have nothing to fear. On momentum oscillators front, ‘RSI’ has touched 41.96 on daily chart, which may remain a cause for concern. If the price breaks below $240.08 level on closing basis, then we may see more profit booking and the stock may show further weakness. On the flipside, hitting the $246.2 mark may result into a pull-back move towards $247.54 level.
On 10th of January, UnitedHealth Group Incorporated (NYSE:UNH) shares ended higher after a volatile session. The shares accumulated 1.23 points or 0.5 percent at $244.87 with a light trade volume of 3.325 million shares. After opening the session at $242.08, the shares went as high as $245.14 and as low as $241.41, the range within which the stock’s price traded throughout the day. The firm is left with a market cap of $239 billion and now has 977.57 million shares outstanding. UnitedHealth Group Incorporated (UNH) stock has lost -8.13 percent of market value in 21 trading days.
UNH stock has a trailing 3-year beta of 0.88, offering the possibility of a lower rate of return, but also posing less risk. The portion of a company’s profit allocated to each outstanding share of common stock was $11.53 a share in the trailing twelve months. The stock’s value has fallen -1.71 percent year to date (YTD) against a rise of 8.41 percent in 12 month’s time. The company’s shares still trade -14.96 percent away from its 1-year high of $287.94 and 17.45 percent up from 52-week low of $208.48. The average consensus rating on the company is 0, on a scale where 5 equates to a unanimous sell rating. In short, the mean analyst recommendations are calling this stock a buy.
Shares of UnitedHealth Group Incorporated (UNH) are trading at a P/E ratio of 23.81 times earnings reported for the past 12 months. The industry UNH operates in has an average P/E of 22.23. Its P/E ratio went as low as 10.27X and as high as 22.08 over the 5-year span. Further, it is sporting a 1.09 on the Price-to-Sales ratio. Compare this with the industry average P/S of 0.87. 0 percent is the gross profit margin for UnitedHealth Group Incorporated and operating margin sits at 7.7 percent. Along with this, the net profit margin is 5.7 percent.
Let’s take a look at some insider activity at UnitedHealth Group Incorporated (NYSE:UNH) and see the pattern. The earliest insider trade took place on 11/28/2018. Burke Richard T parted with a total of 6.09 thousand shares of company at average share price of $281.72. The total for the sales was set at $1.72 million. After this transaction, the Director account balance stood at 1.8 million shares. The stock lost -13.52 percent since that insider sale. On 11/28/2018, Wilensky Gail R, Director, sold 5.88 thousand shares at a price per share of $279.77. This removed 1.65 million shares from the insider’s fortune and the stock saw a -12.91 percent retreat in value since the news became public. This transaction left 59.44 thousand shares in the Director account.
On 11/09/2018, Director Shine Kenneth Irwin performed a sale transaction worth $44.8 thousand. This sale at $274.83 each has eliminated 0.16 thousand shares from the insider’s portfolio position. Meanwhile, shares have recorded -11.35 percent decrease since the transaction was reported. The insider now is left with 29.15 thousand shares remaining in the account. Nelson Steven H, who performs the EVP & CEO, UnitedHealthcare job, sold 8.14 thousand shares for $2.16 million. The disposal occurred on 09/13/2018 was priced at $265 per share. The share price plunged -8.06 percent since the reporting date. Nelson Steven H now left with a stake of 22.5 thousand UNH stock worth $5.51 million after the insider selling.